ABM....hopefully Mr. Maza has this already well planned with Shire Friedreich's Ataxia trail data being published and possible Orphan Drug Designation for FA plus royalty payment and/or acquisition of ILNS.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.